{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T17:23:30Z","timestamp":1785605010757,"version":"3.56.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,4]]},"DOI":"10.7759\/cureus.91622","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T23:02:36Z","timestamp":1757026956000},"source":"Crossref","is-referenced-by-count":1,"title":["Successful Treatment of Disseminated Carcinomatosis of the Bone Marrow Secondary to Colorectal Cancer With Modified FOLFOX6 Plus Panitumumab: A Case Report"],"prefix":"10.7759","author":[{"given":"Junsei","family":"Noda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray F","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024, 74:229-63. 10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw235","article-title":"ESMO consensus guidelines for the management of patients with metastatic colorectal cancer","volume":"27","author":"Van Cutsem E","year":"2016","unstructured":"Van Cutsem E, Cervantes A, Adam R, et al.. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016, 27:1386-422. 10.1093\/annonc\/mdw235","journal-title":"Ann Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx738","article-title":"Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS","volume":"29","author":"Yoshino T","year":"2018","unstructured":"Yoshino T, Arnold D, Taniguchi H, et al.. Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS. Ann Oncol. 2018, 29:44-70. 10.1093\/annonc\/mdx738","journal-title":"Ann Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Cervantes A","year":"2023","unstructured":"Cervantes A, Adam R, Rosell\u00f3 S, et al.. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023, 34:10-32. 10.1016\/j.annonc.2022.10.003","journal-title":"Ann Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.4428","article-title":"Panitumumab vs bevacizumab added to standard first-line chemotherapy and overall survival among patients with RAS wild-type, left-sided metastatic colorectal cancer: a randomized clinical trial","volume":"329","author":"Watanabe J","year":"2023","unstructured":"Watanabe J, Muro K, Shitara K, et al.. Panitumumab vs bevacizumab added to standard first-line chemotherapy and overall survival among patients with RAS wild-type, left-sided metastatic colorectal cancer: a randomized clinical trial. JAMA. 2023, 329:1271-82. 10.1001\/jama.2023.4428","journal-title":"JAMA"},{"key":"ref6","article-title":"Disseminated intravascular coagulation in solid tumors: clinical and pathologic study","volume":"86","author":"Sallah S","year":"2001","unstructured":"Sallah S, Wan JY, Nguyen NP, Hanrahan LR, Sigounas G. Disseminated intravascular coagulation in solid tumors: clinical and pathologic study. Thromb Haemost. 2001, 86:828-33.","journal-title":"Thromb Haemost"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2010.06289.x","article-title":"Clinicopathologic features and clinical outcomes of gastric cancer that initially presents with disseminated intravascular coagulation: a retrospective study","volume":"25","author":"Rhee J","year":"2010","unstructured":"Rhee J, Han SW, Oh DY, Im SA, Kim TY, Bang YJ. Clinicopathologic features and clinical outcomes of gastric cancer that initially presents with disseminated intravascular coagulation: a retrospective study. J Gastroenterol Hepatol. 2010, 25:1537-42. 10.1111\/j.1440-1746.2010.06289.x","journal-title":"J Gastroenterol Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.3810","article-title":"Disseminated carcinomatosis of the bone marrow from rectal cancer: a case report","volume":"9","author":"Yoshida K","year":"2021","unstructured":"Yoshida K, Oyama T, Takahata T, et al.. Disseminated carcinomatosis of the bone marrow from rectal cancer: a case report. Clin Case Rep. 2021, 9:1483-9. 10.1002\/ccr3.3810","journal-title":"Clin Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1986.00360220193031","article-title":"Tumors of unknown origin in the bone marrow","volume":"146","author":"Ringenberg QS","year":"1986","unstructured":"Ringenberg QS, Doll DC, Yarbro JW, Perry MC. Tumors of unknown origin in the bone marrow. Arch Intern Med. 1986, 146:2027-8. 10.1001\/archinte.1986.00360220193031","journal-title":"Arch Intern Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i43.12249","article-title":"Recent aspects for disseminated carcinomatosis of the bone marrow associated with gastric cancer: what has been done for the past, and what will be needed in future?","volume":"21","author":"Iguchi H","year":"2015","unstructured":"Iguchi H. Recent aspects for disseminated carcinomatosis of the bone marrow associated with gastric cancer: what has been done for the past, and what will be needed in future?. World J Gastroenterol. 2015, 21:12249-60. 10.3748\/wjg.v21.i43.12249","journal-title":"World J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/23247096211012224","article-title":"Recurrent colon cancer: presentation with disseminated intravascular coagulation from disseminated carcinomatosis of the bone marrow","volume":"9","author":"Desikan SP","year":"2021","unstructured":"Desikan SP, Mclaughlin N, McClain C, Desikan R. Recurrent colon cancer: presentation with disseminated intravascular coagulation from disseminated carcinomatosis of the bone marrow. J Investig Med High Impact Case Rep. 2021, 9:23247096211012224. 10.1177\/23247096211012224","journal-title":"J Investig Med High Impact Case Rep"},{"key":"ref12","article-title":"Successful initial treatment with weekly 24-hour infusion of 5-fluorouracil and leucovorin in a rectal cancer patient with acute disseminated intravascular coagulation","volume":"52","author":"Huang WT","year":"2005","unstructured":"Huang WT, Chang KC, Shan YS, Tsao CJ, Lee JC. Successful initial treatment with weekly 24-hour infusion of 5-fluorouracil and leucovorin in a rectal cancer patient with acute disseminated intravascular coagulation. Hepatogastroenterology. 2005, 52:1436-9.","journal-title":"Hepatogastroenterology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1159\/000365001","article-title":"A report of disseminated carcinomatosis of the bone marrow originating from transverse colon cancer successfully treated with chemotherapy using XELOX plus bevacizumab","volume":"7","author":"Naito M","year":"2014","unstructured":"Naito M, Yoshida Y, Aisu N, et al.. A report of disseminated carcinomatosis of the bone marrow originating from transverse colon cancer successfully treated with chemotherapy using XELOX plus bevacizumab. Case Rep Oncol. 2014, 7:426-34. 10.1159\/000365001","journal-title":"Case Rep Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.9738\/INTSURG-D-13-00130.1","article-title":"Rectal cancer with disseminated carcinomatosis of the bone marrow: report of a case","volume":"99","author":"Nakashima Y","year":"2014","unstructured":"Nakashima Y, Takeishi K, Guntani A, et al.. Rectal cancer with disseminated carcinomatosis of the bone marrow: report of a case. Int Surg. 2014, 99:518-22. 10.9738\/INTSURG-D-13-00130.1","journal-title":"Int Surg"},{"key":"ref15","article-title":"Disseminated intravascular coagulation as clinical manifestation of colorectal cancer: a case report and review of the literature","volume":"72","author":"van Bunderen CC","year":"2014","unstructured":"van Bunderen CC, de Weger VA, Griffioen-Keijzer A. Disseminated intravascular coagulation as clinical manifestation of colorectal cancer: a case report and review of the literature. Neth J Med. 2014, 72:186-9.","journal-title":"Neth J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2016.1029","article-title":"Favorable control of advanced colon adenocarcinoma with severe bone marrow metastasis: a case report","volume":"5","author":"Hanamura F","year":"2016","unstructured":"Hanamura F, Shibata Y, Shirakawa T, et al.. Favorable control of advanced colon adenocarcinoma with severe bone marrow metastasis: a case report. Mol Clin Oncol. 2016, 5:579-82. 10.3892\/mco.2016.1029","journal-title":"Mol Clin Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.5983","article-title":"Disseminated carcinomatosis of the bone marrow with disseminated intravascular coagulation as the first symptom of recurrent rectal cancer successfully treated with chemotherapy: a case report and review of the literature","volume":"13","author":"Takeyama H","year":"2017","unstructured":"Takeyama H, Sakiyama T, Wakasa T, et al.. Disseminated carcinomatosis of the bone marrow with disseminated intravascular coagulation as the first symptom of recurrent rectal cancer successfully treated with chemotherapy: a case report and review of the literature. Oncol Lett. 2017, 13:4290-4. 10.3892\/ol.2017.5983","journal-title":"Oncol Lett"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S129275","article-title":"Long-term survival after a favorable response to anti-EGFR antibody plus chemotherapy to treat bone marrow metastasis: a case report of KRAS-wildtype rectal cancer","volume":"10","author":"Nakamura S","year":"2017","unstructured":"Nakamura S, Fukui T, Suzuki S, Takeda H, Watanabe K, Yoshioka T. Long-term survival after a favorable response to anti-EGFR antibody plus chemotherapy to treat bone marrow metastasis: a case report of KRAS-wildtype rectal cancer. Onco Targets Ther. 2017, 10:1143-7. 10.2147\/OTT.S129275","journal-title":"Onco Targets Ther"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-018-0083-5","article-title":"Genomic and expression profiling reveal molecular heterogeneity of disseminated tumor cells in bone marrow of early breast cancer","volume":"4","author":"Magbanua MJ","year":"2018","unstructured":"Magbanua MJ, Rugo HS, Hauranieh L, et al.. Genomic and expression profiling reveal molecular heterogeneity of disseminated tumor cells in bone marrow of early breast cancer. NPJ Breast Cancer. 2018, 4:31. 10.1038\/s41523-018-0083-5","journal-title":"NPJ Breast Cancer"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14192172","article-title":"Single-cell analysis of bone-marrow-disseminated tumour cells","volume":"14","author":"So KW","year":"2024","unstructured":"So KW, Su Z, Cheung JP, Choi SW. Single-cell analysis of bone-marrow-disseminated tumour cells. Diagnostics (Basel). 2024, 14:2172. 10.3390\/diagnostics14192172","journal-title":"Diagnostics (Basel)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/395456-successful-treatment-of-disseminated-carcinomatosis-of-the-bone-marrow-secondary-to-colorectal-cancer-with-modified-folfox6-plus-panitumumab-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T23:02:42Z","timestamp":1757026962000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/395456-successful-treatment-of-disseminated-carcinomatosis-of-the-bone-marrow-secondary-to-colorectal-cancer-with-modified-folfox6-plus-panitumumab-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,4]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.91622","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,4]]}}}